1887
Preview this article:

There is no abstract available.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/00222615-44-6-397
1996-06-01
2022-01-22
Loading full text...

Full text loading...

/deliver/fulltext/jmm/44/6/medmicro-44-6-397.html?itemId=/content/journal/jmm/10.1099/00222615-44-6-397&mimeType=html&fmt=ahah

References

  1. Joint Committee on Vaccination and Immunization Immunisation against infectious disease. London HMSO 1992100–103
    [Google Scholar]
  2. Immunization Practices Advisory Committee Pneumococcal polysaccharide vaccine. MMWR 1989; 38:64–75
    [Google Scholar]
  3. Macfarlane J. The clinical impact of pneumococcal disease. In Mayon-White R. T. (ed) The clinical impact of pneumococcal disease and strategies for its prevention (International Congress and Symposium Series 210) London: Royal Society of Medicine; 19959–17
    [Google Scholar]
  4. Macfarlane J. T., Colville A., Guion A., Macfarlane R. M., Rose D. H. Prospective study of aetiology and outcome of adult lower-respiratory-tract infections in the community. Lancet 1993; 341:511–514
    [Google Scholar]
  5. Robbins J. B., Austrian R., Lee C.-J. Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J Infect Dis 1983; 148:1136–1159
    [Google Scholar]
  6. Smit P., Oberholzer D., Hayden-Smith S., Koomhof H. J., Hilleman M. R. Protective efficacy of pneumococcal polysaccharide vaccines. JAMA 1977; 238:2613–2616
    [Google Scholar]
  7. Fine M. J., Smith M. A., Carson C. A. Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials. Arch Intern Med 1994; 154:2666–2677
    [Google Scholar]
  8. Simberkoff M. S., Cross A. P., Al-Ibrahim M. Efficacy of pneumococcal vaccine in high risk patients. Results of a Veterans Administration Cooperative Study. N Engl J Med 1986; 315:1318–1327
    [Google Scholar]
  9. Sims R. V., Steinmann W. C., McConville J. H., King L. R., Zwick W. C., Schwartz J. S. The clinical effectiveness of pneumococcal vaccine in the elderly. Ann Intern Med 1988; 108:653–657
    [Google Scholar]
  10. Shapiro E. D., Berg A. T., Austrian R. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med 1991; 325:1453–1460
    [Google Scholar]
  11. Bolan G., Broome C. V., Facklam R. R., Plikaytis B. D., Fraser D. W., Schlech W. F. Pneumococcal vaccine efficacy in selected populations in the United States. Ann Intern Med 1986; 104:1–6
    [Google Scholar]
  12. Sisk J. E., Reigelman R. K. Cost effectiveness of vaccination against pneumococcal pneumonia: an update. Ann Intern Med 1986; 104:79–86
    [Google Scholar]
  13. Gable C. B., Holzer S. S., Engelhart L. Pneumococcal vaccine. Efficacy and associated cost savings. JAMA 1990; 264:2910–2915
    [Google Scholar]
  14. Mäkelä P. H. Cost benefit analysis of pneumococcal vaccination. In Mayon-White R. T. (ed) The clinical impact of pneumococcal disease and strategies for its prevention (International Congress and Symposium Series 210) London: Royal Society of Medicine; 199541–47
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/00222615-44-6-397
Loading

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error